For the year ending 2025-12-31, HRMY made $868,453K in revenue. $158,967K in net income. Net profit margin of 18.30%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Net product revenue | 868,453 | |||
| Cost of product sold | 198,342 | |||
| Gross profit | 670,111 | |||
| Research and development | 189,594 | |||
| Sales and marketing | 119,512 | |||
| General and administrative | 152,536 | |||
| Total operating expenses | 461,642 | |||
| Operating income | 208,469 | |||
| Other (expense) income, net | -680 | |||
| Interest expense | 14,649 | |||
| Interest income | 21,924 | |||
| Income before income taxes | 215,064 | |||
| Income tax expense | 56,377 | |||
| Net income | 158,687 | |||
| Unrealized income on investments | 280 | |||
| Comprehensive income | 158,967 | |||
| Basic EPS | 2.76 | |||
| Diluted EPS | 2.71 | |||
| Basic Average Shares | 57,492,277 | |||
| Diluted Average Shares | 58,544,570 | |||
Harmony Biosciences Holdings, Inc. (HRMY)
Harmony Biosciences Holdings, Inc. (HRMY)